Talis Biomedical Corp

NASDAQ:TLIS   3:59:52 PM EDT
4.59
+0.12 (+2.68%)
Earnings Announcements

Talis Biomedical Reports Q3 Revenue Of $200,000

Published: 11/15/2021 21:27 GMT
Talis Biomedical Corp (TLIS) - Q3 Revenue $200,000.
Qtrly Net Loss per Share $1.49.
Revenue is expected to be $1.33 Million
Adjusted EPS is expected to be -$1.28

Next Quarter Revenue Guidance is expected to be $1.18 Million
Next Quarter EPS Guidance is expected to be -$1.23

More details on our Analysts Page.